Korean J Hematol.  2011 Jun;46(2):143-144. 10.5045/kjh.2011.46.2.143.

What should we consider in mixed chimerism after hematopoietic stem cell transplantation?

• Lim J

• KMID: 1782781
• DOI: http://doi.org/10.5045/kjh.2011.46.2.143

Abstract

No abstract available.

MeSH Terms

Chimerism
Hematopoietic Stem Cells

Reference

1. Goh RY, Kim SH, Han JY. Lineage-specific chimerism analysis in nucleated cells, T cells and natural killer cells after myeloablative allogeneic hematopoietic stem cell transplantation. Korean J Hematol. 2011; 46:18–23. PMID: 21461299.

2. Baron F, Baker JE, Storb R, et al. Kinetics of engraftment in patients with hematologic malignancies given allogeneic hematopoietic cell transplantation after nonmyeloablative conditioning. Blood. 2004; 104:2254–2262. PMID: 15226174.

3. Mattsson J, Uzunel M, Brune M, et al. Mixed chimaerism is common at the time of acute graft-versus-host disease and disease response in patients receiving non-myeloablative conditioning and allogeneic stem cell transplantation. Br J Haematol. 2001; 115:935–944. PMID: 11843830.

4. Sairafi D, Remberger M, Uhlin M, Ljungman P, Ringdén O, Mattsson J. Leukemia lineage-specific chimerism analysis and molecular monitoring improve outcome of donor lymphocyte infusions. Biol Blood Marrow Transplant. 2010; 16:1728–1737. PMID: 20542125.

5. Saito B, Fukuda T, Yokoyama H, et al. Impact of T cell chimerism on clinical outcome in 117 patients who underwent allogeneic stem cell transplantation with a busulfan-containing reduced-intensity conditioning regimen. Biol Blood Marrow Transplant. 2008; 14:1148–1155. PMID: 18804045.